Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Layese

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Parkinsonism & Related Disorders|September 9, 2022
The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairsKatia Youssov, Etienne Audureau, Henri Vandendriessche, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|April 18, 2024
Respiratory outcomes and survival after unplanned extubation in the NICU: a prospective cohort study from the SEPREVEN trialHelene Yager, Manon Tauzin, Xavier Durrmeyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
High Diagnostic Value of Transient Elastography for Advanced Fibrosis and Cirrhosis in Patients With Chronic Hepatitis DeltaDominique Roulot, Ségolène Brichler, Richard Layese, et al.
Hepatology (Baltimore, Md.)|February 9, 2017
Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United StatesBenjamin Cadier, Julie Bulsei, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|September 29, 2023
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosisPierre Nahon, Richard Layese, Nathalie Ganne-Carrié, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2021
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative ManagementPierre Nahon, Richard Layese, Carole Cagnot, et al.
European Cytokine Network|December 15, 2018
Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosisJean-Philippe Bastard, Soraya Fellahi, Étienne Audureau, et al.
Annals of Intensive Care|July 2, 2021
Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort studyTomas Urbina, Florence Canoui-Poitrine, Camille Hua, et al.
Hepatology (Baltimore, Md.)|December 21, 2018
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected PatientsDominique Salmon-Ceron, Pierre Nahon, Richard Layese, et al.
Frontiers in Pediatrics|June 16, 2023
Determinants of morbidity and mortality related to health care-associated primary bloodstream infections in neonatal intensive care units: a prospective cohort study from the SEPREVEN trialMorgane Jaloustre, Robert Cohen, Valérie Biran, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Parkinsonism & Related Disorders|September 9, 2022
The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairsKatia Youssov, Etienne Audureau, Henri Vandendriessche, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|April 18, 2024
Respiratory outcomes and survival after unplanned extubation in the NICU: a prospective cohort study from the SEPREVEN trialHelene Yager, Manon Tauzin, Xavier Durrmeyer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
High Diagnostic Value of Transient Elastography for Advanced Fibrosis and Cirrhosis in Patients With Chronic Hepatitis DeltaDominique Roulot, Ségolène Brichler, Richard Layese, et al.
Hepatology (Baltimore, Md.)|February 9, 2017
Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United StatesBenjamin Cadier, Julie Bulsei, Pierre Nahon, et al.
Hepatology (Baltimore, Md.)|September 29, 2023
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosisPierre Nahon, Richard Layese, Nathalie Ganne-Carrié, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2021
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative ManagementPierre Nahon, Richard Layese, Carole Cagnot, et al.
European Cytokine Network|December 15, 2018
Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosisJean-Philippe Bastard, Soraya Fellahi, Étienne Audureau, et al.
Annals of Intensive Care|July 2, 2021
Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort studyTomas Urbina, Florence Canoui-Poitrine, Camille Hua, et al.
Hepatology (Baltimore, Md.)|December 21, 2018
Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected PatientsDominique Salmon-Ceron, Pierre Nahon, Richard Layese, et al.
Frontiers in Pediatrics|June 16, 2023
Determinants of morbidity and mortality related to health care-associated primary bloodstream infections in neonatal intensive care units: a prospective cohort study from the SEPREVEN trialMorgane Jaloustre, Robert Cohen, Valérie Biran, et al.
Pageof 6